These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

253 related items for PubMed ID: 12110122

  • 41. Matrix metalloproteinases as therapeutic targets in arthritic diseases: bull's-eye or missing the mark?
    Mengshol JA, Mix KS, Brinckerhoff CE.
    Arthritis Rheum; 2002 Jan; 46(1):13-20. PubMed ID: 11817584
    [No Abstract] [Full Text] [Related]

  • 42. Preface - Matrix metalloproteinases.
    Fridman R.
    Biochim Biophys Acta Mol Cell Res; 2017 Nov; 1864(11 Pt A):1925-1926. PubMed ID: 28739264
    [No Abstract] [Full Text] [Related]

  • 43.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 44. Effect of the novel anti-NGF monoclonal antibody DS002 on the metabolomics of pain mediators, cartilage and bone.
    Jin D, Yang H, Chen Z, Hong Y, Ma H, Xu Z, Cao B, Fei F, Zhang Y, Wu W, Tang L, Sun R, Wang C, Li J.
    Front Pharmacol; 2024 Nov; 15():1396790. PubMed ID: 39188953
    [Abstract] [Full Text] [Related]

  • 45. Unveiling the bioinformatic genes and their involved regulatory mechanisms in type 2 diabetes combined with osteoarthritis.
    Mao G, Xu W, Wan L, Wang H, Xu S, Zhang L, Li S, Zhang J, Lai Z, Lan Y, Liu J.
    Front Immunol; 2024 Nov; 15():1353915. PubMed ID: 39176085
    [Abstract] [Full Text] [Related]

  • 46.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 47.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 48.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 49. GDF8 inhibition enhances musculoskeletal recovery and mitigates posttraumatic osteoarthritis following joint injury.
    Brightwell CR, Latham CM, Keeble AR, Thomas NT, Owen AM, Reeves KA, Long DE, Patrick M, Gonzalez-Velez S, Abed V, Annamalai RT, Jacobs C, Conley CE, Hawk GS, Stone AV, Fry JL, Thompson KL, Johnson DL, Noehren B, Fry CS.
    Sci Adv; 2023 Dec; 9(48):eadi9134. PubMed ID: 38019905
    [Abstract] [Full Text] [Related]

  • 50.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 51.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 52. Matrix metalloproteinases in arthritis: towards precision medicine.
    Grillet B, Pereira RVS, Van Damme J, Abu El-Asrar A, Proost P, Opdenakker G.
    Nat Rev Rheumatol; 2023 Jun; 19(6):363-377. PubMed ID: 37161083
    [Abstract] [Full Text] [Related]

  • 53.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 54.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 55. Mesenchymal stem cells-derived microvesicles versus platelet-rich plasma in the treatment of monoiodoacetate-induced temporomandibular joint osteoarthritis in Albino rats.
    AbuBakr N, Fares AE, Mostafa A, Farag DBE.
    Heliyon; 2022 Oct; 8(10):e10857. PubMed ID: 36212013
    [Abstract] [Full Text] [Related]

  • 56.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 57.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 58. Studying molecular signaling in major angiogenic diseases.
    Nathan J, Shameera R, Palanivel G.
    Mol Cell Biochem; 2022 Oct; 477(10):2433-2450. PubMed ID: 35581517
    [Abstract] [Full Text] [Related]

  • 59.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 60. Emerging proteoglycans and proteoglycan-targeted therapies in rheumatoid arthritis.
    Hurysz B, Bottini N.
    Am J Physiol Cell Physiol; 2022 Jun 01; 322(6):C1061-C1067. PubMed ID: 35476502
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 13.